Post by ProBioGen AG

📈 𝗔 𝗖𝗼𝗻𝘃𝗲𝗿𝘀𝗮𝘁𝗶𝗼𝗻 𝘄𝗶𝘁𝗵 𝗣𝗿𝗼𝗕𝗶𝗼𝗚𝗲𝗻’𝘀 𝗖𝗘𝗢 𝗼𝗻 𝗕𝘂𝗶𝗹𝗱𝗶𝗻𝗴 𝗪𝗵𝗮𝘁’𝘀 𝗡𝗲𝘅𝘁 Since joining #ProBioGen in 2024, Dr. Alfred Merz has brought a rare blend of scientific depth, operational discipline, and people-centered leadership—shaping how we strengthen our foundations, expand capabilities, and show up for partners with real ownership. We sat down recently with Dr. Merz to reflect on a defining year, and what comes next for ProBioGen as a high-science #CDMO in a rapidly shifting landscape. 𝗜𝗻 𝘁𝗵𝗶𝘀 𝗰𝗼𝗻𝘃𝗲𝗿𝘀𝗮𝘁𝗶𝗼𝗻, 𝗵𝗲 𝘁𝗮𝗹𝗸𝘀 𝗮𝗯𝗼𝘂𝘁: • The leadership principles that guide his approach • What clients expect today beyond capacity • How ProBioGen is strengthening delivery through operational excellence, platform technologies, and smart digital tools • Where we’re heading across proteins, viral vectors, and advanced therapies; including the GMP ATMP facility milestone at the Berlin Center for Gene and Cell Therapies • How we’re evolving collaboration: more transparency on scope, responsibilities, and value Read the full blog 👇 https://lnkd.in/dKz8p7tD